MEDICA GROUP PLC — Director's Dealing 2023

Apr 28, 2023

National Storage Mechanism | Additional information

RNS Number : 9282X

Medica Group PLC

28 April 2023

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 28 April 2023, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

Name of PDMR	Number of shares subject to option
Stuart Quin		290,594
Richard Jones		205,125
Kevin Terrins		143,081
Sarah Burns		143,081
Marc O'Brien Caroline Byrne Rob Lavis Fiona Carr		153,844 99,329 140,897 82,154
Kim Scanlan		158,321

The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.

1.	Details of PDMR
(a)	Name	1.           Stuart Quin 2.           Richard Jones 3.           Kevin Terrins 4.           Sarah Burns 5.           Marc O'Brien 6.           Caroline Byrne 7.           Rob Lavis 8.           Fiona Carr 9.           Kim Scanlan
2.	Reason for notification
(b)	Position / status	1.           Chief Executive Officer 2.           Chief Financial Officer 3.           Group Director of Corporate Development 4.           Managing Director, UK 5.           Chief Information Officer 6.           Managing Director, Ireland 7.           Group Medical Director 8.           Group Head of Human Resources 9.           Managing Director, US
	Initial notification / amendment	Initial notification in each case
3.	Details of the Issuer
(a)	Name	Medica Group PLC
(b)	LEI	213800B8XE5FUSZF5Z16
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a)	Description of the financial instrument	Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b)	Nature of the transaction	Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017
(c)	Price(s) and volume	Option Price nil in each case 1.           290,594 2.           205,125 3.           143,081 4.           143,081 5.           153,844 6.           99,329 7.           140,897 8.           82,154 9.           158,321
(d)	Aggregated information	N/A
(e)	Date of the transaction	28 April 2023
(f)	Place of the transaction	Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHNKFBPNBKDAQB